Lisata Therapeutics News

Lisata Therapeutics | EFFECT: Others

May 10 06:09 ET

Lisata Therapeutics | 424B5: Prospectus

Sep 26, 2022 16:20 ET

Caladrius Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Sep 2, 2022 16:01 ET

Caladrius Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Aug 15, 2022 06:46 ET

Caladrius Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Aug 10, 2022 08:08 ET

Caladrius Biosciences | 424B3: Prospectus

Jul 29, 2022 16:06 ET

Caladrius Biosciences | EFFECT: Others

Jul 29, 2022 00:15 ET

Caladrius Biosciences | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Jul 26, 2022 16:45 ET

Caladrius Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 6, 2022 16:05 ET

Caladrius Biosciences | S-4: Registration of securities issued in business combination transactions

Jun 15, 2022 17:06 ET

Caladrius Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jun 9, 2022 16:01 ET

Caladrius Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Apr 27, 2022 17:26 ET

Caladrius Biosciences | 424B5: Prospectus

Jun 4, 2021 16:45 ET

Caladrius Biosciences | 424B2: Prospectus

May 6, 2021 16:07 ET

Caladrius Biosciences | EFFECT: Others

May 5, 2021 00:15 ET

Caladrius Biosciences | 424B5: Prospectus

Feb 16, 2021 16:49 ET

Caladrius Biosciences | 424B5: Prospectus

Feb 16, 2021 16:46 ET

Caladrius Biosciences | 424B5: Prospectus

Feb 12, 2021 07:46 ET

Caladrius Biosciences | EFFECT: Others

Feb 8, 2021 00:15 ET

Caladrius Biosciences | 424B3: Prospectus

Feb 5, 2021 16:42 ET